Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis

The potential of autologous cell‐based therapies including those using multipotent mesenchymal stromal cells (MSCs) is being investigated for multiple sclerosis (MS) and other neurological conditions. However, the phenotype of MSC in neurological diseases has not been fully characterized. We have pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stem Cells Transl Med
Hauptverfasser: Redondo, Juliana, Sarkar, Pamela, Kemp, Kevin, Heesom, Kate J, Wilkins, Alastair, Scolding, Neil J, Rice, Claire M
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Inc. 2018
Schlagworte:
Translational Research Articles and Reviews
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6186266/
https://ncbi.nlm.nih.gov/pubmed/30063300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.18-0045
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge